If approved, commercial launch would follow, likely in late 2026 or early 2027
The amount of active peptide in that volume depends entirely on the concentration of the reconstituted solution
Research suggests the peptide may interact with neurotransmitter systems including the dopaminergic, serotonergic, and GABAergic pathways, though these findings remain in the preclinical stage
This multi-pathway approach explains both the peptides remarkable healing effects across different tissue types and the complexity of predicting its behavior in various biological contexts
This co-localization suggests that DSIP may play a modulatory role in hormone regulation, stress responses, and metabolic processes
In a separate trial, topical GHK-Cu was compared head-to-head with vitamin C cream and retinoic acid for collagen improvement